Tudor Investment Corp ET AL Boosts Stake in CorVel Co. (NASDAQ:CRVL)

Tudor Investment Corp ET AL grew its position in shares of CorVel Co. (NASDAQ:CRVL - Free Report) by 175.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 49,533 shares of the business services provider's stock after buying an additional 31,523 shares during the quarter. Tudor Investment Corp ET AL owned 0.10% of CorVel worth $5,511,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Barclays PLC lifted its stake in CorVel by 380.8% during the 3rd quarter. Barclays PLC now owns 15,977 shares of the business services provider's stock valued at $5,223,000 after acquiring an additional 12,654 shares during the period. Franklin Resources Inc. lifted its position in CorVel by 9.9% during the third quarter. Franklin Resources Inc. now owns 1,917 shares of the business services provider's stock valued at $614,000 after purchasing an additional 173 shares during the period. JPMorgan Chase & Co. boosted its holdings in CorVel by 106.6% in the third quarter. JPMorgan Chase & Co. now owns 38,113 shares of the business services provider's stock worth $12,459,000 after purchasing an additional 19,667 shares during the last quarter. GAMMA Investing LLC grew its position in CorVel by 175.2% in the 4th quarter. GAMMA Investing LLC now owns 432 shares of the business services provider's stock worth $48,000 after purchasing an additional 275 shares during the period. Finally, Everence Capital Management Inc. raised its stake in CorVel by 192.5% during the 4th quarter. Everence Capital Management Inc. now owns 6,990 shares of the business services provider's stock valued at $778,000 after buying an additional 4,600 shares during the last quarter. Institutional investors own 51.36% of the company's stock.

CorVel Stock Performance

Shares of NASDAQ CRVL traded up $0.36 during midday trading on Tuesday, hitting $110.88. 17,311 shares of the company's stock traded hands, compared to its average volume of 119,050. The firm has a fifty day moving average of $110.42 and a 200 day moving average of $115.89. CorVel Co. has a 1 year low of $76.53 and a 1 year high of $128.61. The stock has a market capitalization of $5.69 billion, a price-to-earnings ratio of 65.12 and a beta of 1.10.

CorVel (NASDAQ:CRVL - Get Free Report) last announced its earnings results on Tuesday, February 4th. The business services provider reported $0.46 EPS for the quarter. CorVel had a net margin of 10.12% and a return on equity of 32.22%.

Insider Buying and Selling

In related news, Director Steven J. Hamerslag sold 10,000 shares of the company's stock in a transaction on Thursday, February 6th. The shares were sold at an average price of $123.48, for a total value of $1,234,800.00. Following the completion of the transaction, the director now owns 314,000 shares of the company's stock, valued at approximately $38,772,720. This represents a 3.09 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Alan Hoops sold 10,200 shares of the firm's stock in a transaction dated Tuesday, February 18th. The shares were sold at an average price of $116.39, for a total value of $1,187,178.00. Following the sale, the director now directly owns 118,213 shares in the company, valued at approximately $13,758,811.07. This represents a 7.94 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 48,723 shares of company stock valued at $5,757,140. 47.57% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

Separately, StockNews.com raised CorVel from a "hold" rating to a "buy" rating in a report on Friday, April 18th.

CorVel Profile

CorVel Corporation provides workers' compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.